Jane Street Group, LLC Voyager Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 84,652 shares of VYGR stock, worth $489,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,652

Previous 192,793 56.09%

Holding current value

$489,288

Previous $1.52 Million 67.52%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $623,973 - $1 Million	-108,141 Reduced 56.09%	84,652 $495,000
Q2 2024 Aug 14, 2024	BUY	$7.42 - $10.54 $1.12 Million - $1.59 Million	151,274 Added 364.35%	192,793 $1.52 Million
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $296,860 - $450,065	41,519 New	41,519 $386,000
Q2 2023 Aug 14, 2023	SELL	$6.94 - $13.99 $883,170 - $1.78 Million	-127,258 Reduced 73.6%	45,658 $522,000
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $887,082 - $1.59 Million	147,847 Added 589.76%	172,916 $1.33 Million
Q4 2022 Feb 14, 2023	BUY	$4.94 - $6.61 $123,840 - $165,706	25,069 New	25,069 $152,000
Q2 2022 Aug 16, 2022	SELL	$4.82 - $10.09 $308,219 - $645,215	-63,946 Reduced 78.88%	17,124 $102,000
Q1 2022 May 17, 2022	BUY	$2.75 - $9.44 $185,303 - $636,095	67,383 Added 492.31%	81,070 $618,000
Q4 2021 Feb 15, 2022	BUY	$2.47 - $5.55 $33,806 - $75,962	13,687 New	13,687 $37,000
Q1 2021 May 18, 2021	SELL	$4.61 - $9.04 $81,112 - $159,058	-17,595 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$7.15 - $12.28 $125,804 - $216,066	17,595 New	17,595 $126,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $157,711 - $207,288	-12,302 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $200,645 - $348,023	12,302 New	12,302 $212,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Voyager Therapeutics, Inc. Transaction History